0001493152-23-006669.txt : 20230303
0001493152-23-006669.hdr.sgml : 20230303
20230303160549
ACCESSION NUMBER: 0001493152-23-006669
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230223
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COMMODORE CAPITAL LP
CENTRAL INDEX KEY: 0001831942
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40505
FILM NUMBER: 23703817
BUSINESS ADDRESS:
STREET 1: 444 MADISON AVENUE
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 917-970-1730
MAIL ADDRESS:
STREET 1: 444 MADISON AVENUE
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ambrx Biopharma Inc.
CENTRAL INDEX KEY: 0001836056
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 571147346
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10975 NORTH TORREY PINES ROAD
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 729-3339
MAIL ADDRESS:
STREET 1: 10975 NORTH TORREY PINES ROAD
CITY: LA JOLLA
STATE: CA
ZIP: 92037
3
1
ownership.xml
X0206
3
2023-02-23
0
0001836056
Ambrx Biopharma Inc.
AMAM
0001831942
COMMODORE CAPITAL LP
444 MADISON AVENUE
35TH FLOOR
NEW YORK
NY
10022
0
0
1
0
Ordinary Shares
35700000
I
By Commodore Capital Master LP
The ordinary shares of the Issuer, par value $0.0001 per share (the "Ordinary Shares") may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares.
As of February 23, 2023, the Reporting Person owns 5,100,000 ADSs, representing 35,700,000 Ordinary Shares.
The securities are held directly by Commodore Capital Master LP ("Commodore Master"). Commodore Capital LP ("Commodore Capital") is the investment manager to Commodore Master. Michael Kramarz and Robert Egen Atkinson are the managing partners of Commodore Capital and exercise investment and dispositive power over the securities held by Commodore Master. Each of Commodore Capital, Dr. Kramarz and Dr. Atkinson disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that Commodore Capital, Commodore Master, Dr. Kramarz and Dr. Atkinson or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
/s/ Michael Kramarz, Managing Partner
2023-03-03